ANIX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Anixa Biosciences Inc (ANIX) is not a strong buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The technical indicators suggest a neutral to bearish trend, options data reflects low trading sentiment, and the financial performance shows no growth with declining net income and EPS. Additionally, there are no recent positive news catalysts or significant trading trends to support a buy decision.
The MACD is slightly positive at 0.0182, indicating weak bullish momentum. RSI is neutral at 51.147, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support and resistance levels are Pivot: 2.869, R1: 3.001, S1: 2.738, R2: 3.083, S2: 2.656. The stock has a 70% chance of declining in the short term (-0.94% next day, -3.65% next week, -5.96% next month).
NULL identified. No recent news, no significant hedge fund or insider trading activity, and no congress trading data.
Declining financial performance (net income and EPS down YoY), bearish moving averages, and a high probability of short-term price decline based on candlestick pattern analysis.
In Q4 2025, revenue remained at 0 with no YoY growth. Net income dropped to -$2,695,000 (-6.52% YoY), and EPS fell to -0.08 (-11.11% YoY). Gross margin remained at 0 with no improvement.
No analyst rating or price target data available.
